Capstone Holding Corp. — Director's Dealing 2015

Jan 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2015-01-02

Reporting Person: TAEGER LESLIE M (SVP Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-01-02	Stock Option (Right to Buy)	$0.22	A	50000	Acquired	2025-01-02	Common Stock (50000)	Direct

Footnotes

F1: 50% to vest 1/2/15 and 50% to vest monthly by 1/2/16